Page last updated: 2024-11-07

spironolactone and Bronchiolitis, Viral

spironolactone has been researched along with Bronchiolitis, Viral in 1 studies

Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.

Bronchiolitis, Viral: An acute inflammatory disease of the lower RESPIRATORY TRACT, caused by paramyxoviruses, occurring primarily in infants and young children; the viruses most commonly implicated are PARAINFLUENZA VIRUS TYPE 3; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; and METAPNEUMOVIRUS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stagnara, J1
Balagny, E1
Cossalter, B1
Dommerges, JP1
Dournel, C1
Drahi, E1
Gauchez, H1
Guillot, F1
Javault, D1
Lagardère, B1
Le Masne, A1
Lesprit, E1
Maidenberg, M1
Maufroy, D1
Picherot, G1
Renaud, H1
Robert, J1
Undreiner, F1

Other Studies

1 other study available for spironolactone and Bronchiolitis, Viral

ArticleYear
[Management of bronchiolitis in the infant. Recommendations. Long text].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2001, Volume: 8 Suppl 1

    Topics: Acute Disease; Anti-Inflammatory Agents; Antiviral Agents; Bronchiolitis, Viral; Bronchodilator Agen

2001